The efficacy of platelet-rich plasma therapy in the treatment of androgenetic alopecia: a literature review

Abstract

Androgenetic alopecia is a genetically determined disease characterized by gradual thinning of hair, which subsequently leads to hair loss, and thereby significantly affects a patient’s quality of life. The existing methods of disease management have a number of side effects and drawbacks. Thus, new treatment methods combining both high tolerance and efficacy are continuously determined. This current review presents an analysis of the effectiveness of single- and double-spin preparation methods of platelet-rich plasma for the management of patients with androgenetic alopecia.

Keywords

alopecia / androgenetic alopecia / PRP therapy / growth factors

References

[1] Kaliyadan F, Nambiar A, Vijayaraghavan S. Androgenetic alopecia: an update. Indian J Dermatol Venereol Leprol. 2013;79(5):613-25. doi: 10.4103/0378-6323.116730

[2] Kaliyadan F., Nambiar A., Vijayaraghavan S. Androgenetic alopecia: an update. Indian J Dermatol Venereol Leprol. 2013;79(5):613-25. doi:10.4103/0378-6323.116730

[3] Gupta AK, Mays RR, Dotzert MS, Versteeg SG, Shear NH, Piguet V. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis. J Eur Acad Dermatol Venereol. 2018;32(12):2112-25.

[4] Gupta A.K., Mays R.R., Dotzert M.S., Versteeg S.G., Shear N.H., Piguet V. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis. J Eur Acad Dermatol Venereol. 2018;32(12):2112-25.

[5] Gkini MA, Kouskoukis AE, Tripsianis G, Rigopoulos D, Kouskoukis K. Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period. J Cutan Aesthet Surg 2014;7(4):213-9.

[6] Gkini M.A., Kouskoukis A.E., Tripsianis G., Rigopoulos D., Kouskoukis K. Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period. J Cutan Aesthet Surg 2014;7(4):213-9.

[7] Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP?. Implant Dent. 2001;10(4):225-8.

[8] Marx R.E. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225-228.

[9] Motosko CC, Khouri KS, Poudrier G, Sinno S, Hazen A. Evaluating Platelet-Rich Therapy for Facial Aesthetics and Alopecia: A Critical Review of the Literature. Plast Reconstr Surg. 2018;141(5):1115-23.

[10] Motosko C.C., Khouri K.S., Poudrier G., Sinno S., Hazen A. Evaluating Platelet-Rich Therapy for Facial Aesthetics and Alopecia: A Critical Review of the Literature. Plast Reconstr Surg. 2018;141(5):1115-23.

[11] Karagadyan AD. Use of autologous platelet-rich plasma in dermatocosmetology (review). Russian Journal of Skin and Venereal Diseases. 2017;20(6):368-72. (in Russian)

[12] Карагадян А.Д. Применение аутологичной, богатой тромбоцитами плазмы в дерматологической и косметологической практике (обзор) // Российский журнал кожных и венерических болезней. 2017;20(6):368-72.

[13] Merchan WH, Gomez LA, Chasoy ME, Alfonso-Rodriguez CA, Munoz AL. Platelet-rich plasma, a powerful tool in dermatology. J Tissue Eng Regen Med. 2019;13(5):892-901.

[14] Merchan W.H., Gomez L.A., Chasoy M.E., Alfonso-Rodríguez C.A., Munoz A.L. Platelet-rich plasma, a powerful tool in dermatology. J Tissue Eng Regen Med. 2019;13(5):892-901.

[15] Olisova OYu, Egorova KG. Platelet-rich plasma in the treatment of non-scarring alopecia. Russian Journal of Skin and Venereal Diseases. 2014;17(6):60-2. (in Russian)

[16] Олисова О.Ю., Егорова К.Г. Богатая тромбоцитами плазма в терапии нерубцовых алопеций // Российский журнал кожных и венерических болезней. 2014;17(6):60-2.

[17] Alves R, Grimalt R. Randomized placebo-controlled, double-blind, half-head Study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia. Dermatol Surg. 2016;42(4):491-7.

[18] Alves R., Grimalt R. Randomized placebo-controlled, double-blind, half-head Study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia. Dermatol Surg. 2016;42(4):491-7.

[19] Ayatollahi A, Hosseini H, Shahdi M, Nasrollahi SA, Kashani MN, Yadangi S, et al. Platelet-rich plasma by single spin process in male pattern androgenetic alopecia: is it an effective treatment? Indian Dermatol Online J. 2017;8(6):460-4. doi: 10.4103/idoj.IDOJ_11_17

[20] Ayatollahi A., Hosseini H., Shahdi M., Nasrollahi S.A., Kashani M.N., Yadangi S., et al. Platelet-rich plasma by single spin process in male pattern androgenetic alopecia: is it an effective treatment? Indian Dermatol Online J. 2017;8(6):460-4. doi: 10.4103/idoj.IDOJ_11_17

[21] Schiavone G, Raskovic D, Greco J, Abeni D. Platelet-rich plasma for androgenetic alopecia: a pilot study. Dermatol Surg. 2014;40(9):1010-9.

[22] Schiavone G., Raskovic D., Greco J., Abeni D. Platelet-rich plasma for androgenetic alopecia: a pilot study. Dermatol Surg. 2014;40(9):1010-9.

[23] Singhal P, Agarwal S, Dhot PS, Sayal SK. Efficacy of platelet- rich plasma in treatment of androgenic alopecia. Asian J Transfus Sci. 2015;9(2):159-62.

[24] Singhal P., Agarwal S., Dhot P.S., Sayal S.K. Efficacy of platelet-rich plasma in treatment of androgenic alopecia. Asian J Transfus Sci. 2015;9(2):159-62.

[25] Mapar MA, Shahriari S, Haghighizadeh MH. Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: A pilot randomized controlled trial. J Cosmet Laser Ther. 2016;18(8):452-5.

[26] Mapar M.A., Shahriari S., Haghighizadeh M.H. Efficacy of platelet-rich plasma in the treatment of androgenetic (male- patterned) alopecia: A pilot randomized controlled trial. J Cosmet Laser Ther. 2016;18(8):452-5.

[27] Gentile P, Garcovich S, Bielli A, Scioli MG, Orlandi A, Cervelli V. The effect of platelet-rich plasma in hair regrowth: A randomized placebo-controlled trial. Stem Cells Transl Med. 2015;4(11):1317-23. doi: 10.5966/sctm.2015-0107

[28] Gentile P., Garcovich S., Bielli A., Scioli M.G., Orlandi A., Cervelli V. The effect of platelet-rich plasma in hair regrowth: A randomized placebo-controlled trial. Stem Cells Transl Med. 2015;4(11):1317-23. doi: 10.5966/sctm.2015-0107

[29] Puig CJ, Reese R, Peters M. Double-blind, placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia. Dermatol Surg. 2016;42(11):1243-7.

[30] Puig C.J., Reese R., Peters M. Double-blind, placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia. Dermatol Surg. 2016;42(11):1243-7.

[31] Verma K, Tegta GR, Verma G, Gupta M, Negi A, Sharma R. A study to compare the efficacy of platelet-rich plasma and minoxidil therapy for the treatment of androgenetic alopecia. Int J Trichol. 2019;11(2):68-79.

[32] Verma K., Tegta G.R., Verma G., Gupta M., Negi A., Sharma R. A study to compare the efficacy of platelet-rich plasma and minoxidil therapy for the treatment of androgenetic alopecia. Int J Trichol. 2019;11(2):68-79.

[33] Takikawa M, Nakamura S, Nakamura Shingo, Ishirara M, Kishimoto S, Sasaki K, et al. Enhanced effect of platelet-rich plasma containing a new carrier on hair growth. Dermatol Surg. 2011;37(12):1721-9.

[34] Takikawa M., Nakamura S., Nakamura Shingo, Ishirara M., Kishimoto S., Sasaki K., et al. Enhanced effect of platelet-rich plasma containing a new carrier on hair growth. Dermatol Surg. 2011;37(12):1721-9.

[35] Butt G, Hussain I, Ahmad FJ, Choudhery MS. Stromal vascular fraction-enriched platelet-rich plasma therapy reverses the effects of androgenetic alopecia. J Cosmet Dermatol. 2020;19(5):1078-85.

[36] Butt G., Hussain I., Ahmad F.J., Choudhery M.S. Stromal vascular fraction-enriched platelet-rich plasma therapy reverses the effects of androgenetic alopecia. J Cosmet Dermatol. 2020;19(5):1078-85.

[37] Stefanis AJ, Groh T, Arenbergerova M, Arenberger P, Bauer PO. Stromal vascular fraction and its role in the management of alopecia: A review. J Clin Aesthet Dermatol. 2019;12(11):35-44.

[38] Stefanis A.J., Groh T., Arenbergerova M., Arenberger P., Bauer P.O. Stromal vascular fraction and its role in the management of alopecia: A review. J Clin Aesthet Dermatol. 2019;12(11):35-44.

[39] Oh JH, Kim W, Park KU, Roh YH. Comparison of the cellular composition and cytokine-release kinetics of various platelet-rich plasma preparations. Am J Sports Med. 2015;43(12):3062-70.

[40] Oh J.H., Kim W., Park K.U., Roh Y.H. Comparison of the cellular composition and cytokine-release kinetics of various platelet-rich plasma preparations. Am J Sports Med. 2015;43(12):3062-70.

[41] Seidel SR, Vendruscolo CP, Moreira JJ, Fülber J, Ottaiano TF, Oliva ML, et al. Does double centrifugation lead to premature platelet aggregation and decreased TGF-β1 concentrations in equine platelet-rich plasma? Vet Sci. 2019;6(3):68. doi: 10.3390/vetsci6030068.

[42] Seidel S.R., Vendruscolo C.P., Moreira J.J., Fülber J., Ottaiano T.F., Oliva M.L., et al. Does double centrifugation lead to premature platelet aggregation and decreased TGF-β1 concentrations in equine platelet-rich plasma? Vet Sci. 2019;6(3):68. doi: 10.3390/vetsci6030068.

[43] Giordano S, Romeo M, Lankinen P. Platelet-rich plasma for androgenetic alopecia: Does it work? Evidence from meta analysis. J Cosmet Dermatol. 2017;16(3):374-81.

[44] Giordano S., Romeo M., Lankinen P. Platelet-rich plasma for androgenetic alopecia: Does it work? Evidence from meta-analysis. J Cosmet Dermatol. 2017;16(3):374-81.

[45] Mautner K, Malanga GA, Smith J, Shiple B, Ibrahim V, Sampson S, Bowenet JE. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PMR. 2015;7(4, Suppl):S53-9. doi: 10.1016/j.pmrj.2015.02.005

[46] Mautner K., Malanga G.A., Smith J., Shiple B., Ibrahim V., Sampson S., Bowenet J.E. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PMR. 2015;7(4, Suppl):S53-9. doi: 10.1016/j.pmrj.2015.02.005

[47] Zhuang YW, Zeng YM, Chen YF, Zhang HP, Chen XY, Yang DY, Wu WJ. The effects of different activators on the release curve of human platelet-rich plasma. Zhonghua Jie He He Hu Xi Za Zhi. 2018;41(11):868-72. doi: 10.3760/cma.j.issn.1001-0939.2018.11.008

[48] Zhuang Y.W., Zeng Y.M., Chen Y.F., Zhang H.P., Chen X.Y., Yang D.Y., Wu W.J. The effects of different activators on the release curve of human platelet-rich plasma. Zhonghua Jie He He Hu Xi Za Zhi. 2018;41(11):868-72. doi: 10.3760/cma.j.issn.1001-0939.2018.11.008

[49] Etulain J. Platelets in wound healing and regenerative medicine. Platelets. 2018;29(6):556-68. doi: 10.1080/09537104.2018.1430357

[50] Etulain J. Platelets in wound healing and regenerative medicine. Platelets. 2018;29(6):556-68.

[51] Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg. 2014;7(4):189-97.

[52] Dhurat R., Sukesh M. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author’s Perspective. Cutan Aesthet Surg. 2014;7(4):189-97.

[53] Bansal H, Comella K, Leon J, Verma P, Agrawal D, Koka P, Ichim T. Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis. J Transl Med. 2017;15(1):141.

[54] Bansal H., Comella K., Leon J., Verma P., Agrawal D., Koka P., Ichim T. Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis. J Transl Med. 2017;15(1):141.

[55] Stevens HP, Donners S, de Bruijn J. Introducing platelet-rich stroma: Platelet-Rich Plasma (PRP) and Stromal Vascular Fraction (SVF) combined for the treatment of androgenetic alopecia. Aesthet Surg J. 2018;38(8):811-22.

[56] Stevens H.P., Donners S., de Bruijn J. Introducing platelet-rich stroma: Platelet-Rich Plasma (PRP) and Stromal Vascular Fraction (SVF) combined for the treatment of androgenetic alopecia. Aesthet Surg J. 2018;38(8):811-22.

[57] Usuelli FG, Grassi M, Maccario C, Vigano M, Lanfranchi L, Montrasio UA, de Girolamo L. Intratendinous adipose-derived Stromal Vascular Fraction (SVF) injection provides a safe, efficacious treatment for Achilles tendinopathy: results of a randomized controlled clinical trial at a 6-month follow-up. Knee Surg Sports Traumatol Arthrosc. 2018;26(7):2000-10.

[58] Usuelli F.G., Grassi M., Maccario C., Vigano M., Lanfranchi L., Montrasio U.A., de Girolamo L. Intratendinous adipose-derived Stromal Vascular Fraction (SVF) injection provides a safe, efficacious treatment for Achilles tendinopathy: results of a randomized controlled clinical trial at a 6-month follow-up. Knee Surg Sports Traumatol Arthrosc. 2018;26(7):2000-10.

[59] Lolli F, Pallotti F, Rossi A, Fortuna MC, Caro G, Lenzi A, et al. Androgenetic alopecia: a review. Endocrine. 2017;57(1):9-17.

[60] Lolli F., Pallotti F., Rossi A., Fortuna M.C., Caro G., Lenzi A., et al. Androgenetic alopecia: a review. Endocrine. 2017;57(1):9-17.

RIGHTS & PERMISSIONS

Eco-Vector